medical news releases
medical news releases with http://www.medical-mailings.com

medical news releases

medical mailings

News for 10-May-21

Source: MedicineNet Diabetes General
Standing or 'Easy' Walks May Help Type 2 Diabetics Control Blood Sugar

Source: MedicineNet Diabetes General
Daily Can of Soda Boosts Odds for Prediabetes, Study Finds

Source: MedicineNet Asthma General
Mice May Be Key to Kids' Asthma Attacks at School

Source: MedicineNet Asthma General
ephedrine (oral)

Source: MedicineNet Asthma General
Bronchodilators (Drug Class)

Source: MedicineNet Asthma General
Study Sees Link Between Insomnia, Asthma

Source: MedicineNet Asthma General
Oximetry

Source: MedicineNet Diabetes General
Health Tip: Creating an Insulin Routine

Source: MedicineNet Asthma General
Occupational Asthma

Source: MedicineNet Asthma General
Churg-Strauss Syndrome

Search the Web
medicine,
medical news releases
human resources
adoption medical news
laparoscopic surgeon
nursing school info,
outpatient surgery software
licensed vocational nurse,
shopping,
portland wellness programs

The Best medical news releases website

All the medical news releases information you need to know about is right here. Presented and researched by http://www.medical-mailings.com. We've searched the information super highway far and wide to provide you with the best medical news releases site on the internet today. The links below will assist you in your efforts to find the information that you are looking for about
medical news releases.

medical news releases

medical mailings, email campaigns
Need information on Medical Mailings? Our links will provide you with information on all type of type of Medical Mailings for Physicians over the internet including email and snail mail. For conferencing services to go with your email campagin go to Meetings on the Net - http://www.meetingsonthenet.com
medical mailings, email campaigns

If you're looking for medical news releases in the real world, and not on the Internet, how would you go about it? I guess you could find information about medical news releases in books and magazines, but it's so much easier on the web.

And it's a lot faster too isn't it? Especially when you find medical news releases websites like ours, which cover the exact topic you're looking for. Being able to find exactly what you're looking for - medical news releases - is the real beauty of the Internet.

medical news releases
human resources
adoption medical news
laparoscopic surgeon
nursing school info,
outpatient surgery software
licensed vocational nurse,
shopping,
portland wellness programs
iowa physicians
outpatient surgery pediatrics
fitness wellness programs
surveillance
obesity
roux-en-y
eap
internet health care
medicine,

Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic Suppositories)

 by: ZHANG GUAN HUA, LIANG CHAO, ZHENG WAN PIN

Treating chronic mutational hepatitis B with Chinese medicine Vitalliver (Vigconic suppositories)


ZHANG GUAN HUA, LIANG CHAO, ZHENG WAN PIN


Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China

Research Method:

Quantitative determination by contrasting HBV-DNA of cases before and after the treatment.

Number of cases: 25 (n)

Case Selection: Between the age of 16 and 65, in accordance with the diagnosis standards pf chronic Hepatitis B, with negative e antigen and positive e antibody, HBV-DNA > 1104 cp/mL.

Detection Method: All the blood samples are detected by Sichuan Clinical Detection Center; PCR-ELISA quantitative determination is used within detection range of 1104 - 1107-8, HBV-DNA, unit of measurement is cp/mL.

Direction Plan: one suppository provided by Vigconic (International) Ltd. Bid. The course of treatment is six months, the tracing observation after withdrawal lasts six months.

Observation index:

  1. HBV-DNA response after the treatment.

  2. Lasting HBV-DNA response (six months after withdrawal).

Criterion of Therapeutic Effect:

  1. If HBV-DNA volume 1104 cp/mL: 4/25 (16%)

  2. Lasting response:

HBV-DNA volume 1104 cp/mL: 2/25 (8%)

Among the results of lasting response, 16 blood serum samples are detected through fluorimetric quantitative determination PCR by the instruments of PE.USD, H-7700 in the second attached hospital of Guangzhou Medical College. The result is in accordance with that in Sichuan Clinical Testing Center. (8 cases among it < 1102 cp/mL). The testing range of this testing method is 1102 - 1107-8 cp/mL.

Conclusion

The reason for the repeatedly abnormal liver function of Chronic Hepatitis B (CHB) patients lies in the repeatedly duplication of HBV after infection, which leads to fibrosis of liver, then cirrhosis and liver cancer. It is commonly accepted that if CHB shows the transformation of HBeAg/Anti-HBe, HBV-DNA becoming negative, liver function returning to normal state, the disease is relieved. However, parts of patients with the transformation of HBeAg/Anti-HBe still remain positive in HBV-DNA and the pathological change in the liver continues. Because HBV-DNA occurs promoter mutation in the anterior C section (1896 necleoside G-A variation) or in the C section (1762 nucleoside T variation, 1764 G-A variation), HBeAg cannot come into being. Therefore, the HBeAg in the patient's blood cannot be detected, while the virus can keep on duplicating and fixing itself. Through sequential assay of nucleic acid, it proves that promoter mutation appears in 30%-60% of HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section. In some provinces and cities of the People of China, the percentage of promoter mutation appears in HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section is from 17.6% to 78.9%. Eight out of the 25 cases of our observation go through the sequential assay of nucleic acid carried out by the Department of Microbiology of the University of Hong Kong. It all proves to have HBV-DNA mutation. The chronic mutational Hepatitis B is infectious and apt to cause cirrhosis and liver cancer since the present medicines of antivirus and immuno-modulator do not produce the expected therapeutic effects.

Vitalliver suppository is made up from a formula of Chinese herbs, including Ginseng, Deer Horn, Cordyceps, Radix Astragali, Frudctus Cnidii, Semen Cuscutae, etc. The formula is mainly for strengthening the body resistant and primarily for reinforcing Kidney Qi, which produces good therapeutic effects in treating chronic mutational Hepatitis B. The mechanism is probably that through the regulating of immune system, the duplication of virus is inhibited and meanwhile the liver is protected, so it can produce a lasting therapeutic effect. No adverse reaction and severe accident happens during clinical observation, so it is safe for using. Vitalliver is bringing hopes to the treatment of chronic mutational Hepatitis B.

* The second stage of clinical trial would be carrying out by the Microbiology Department of the University of Hong Kong and Chengdu University of Traditional Chinese Medicine.

For more information, please visit: http://www.vigconic.com


Or, contact:


William Yip cs@vigconic.com


5/F, Cheung Wah Building, Sheung Heung Rd,


Kowloon, Hong Kong


Tel: 852-27656200


Fax: 852-27645314

About The Author

Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China


webmaster@vigconic.com

Google

http://www.gomailings.com/
fantasy-sports-directory | Talk On The Net | MD Newscast | Fantasy Baseball Online | Medical Newscast

Medical Meetings On The Net   RX Right!   Medical Meetings On The Net